STOCK TITAN

ADIA reports 4.9% stake in Medline Inc. (MDLN) via subsidiary

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Medline Inc. ownership update: Abu Dhabi Investment Authority reports beneficial ownership of 41,355,340 shares of Class A Common Stock (including direct and shared holdings), representing 4.9% of the class. Platinum Falcon B 2018 RSC Limited reports 40,838,099 shares, representing 4.8%. The percent calculations are based on 845,611,435 shares outstanding as reported in Medline's March 6, 2026 prospectus.

Positive

  • None.

Negative

  • None.
ADIA total holdings 41,355,340 shares Beneficially owned per filing
Platinum Falcon holdings 40,838,099 shares Direct holdings reported for Platinum Falcon
Percent of class (ADIA) 4.9% Calculated using prospectus outstanding figure
Percent of class (Platinum Falcon) 4.8% Calculated using prospectus outstanding figure
Shares outstanding reference 845,611,435 shares As reported in Medline prospectus dated March 6, 2026
Schedule 13G/A regulatory
"Amendment No. 1 Schedule 13G/A cover disclosures"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: See responses to Item 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
underwriters' over-allotment option financial
"after giving effect to the full exercise of the underwriters' over-allotment option"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





58507V107

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Abu Dhabi Investment Authority is the direct owner of 517,241 of the shares of Class A Common Stock represented herein. (2) The percent calculation is based on 845,611,435 shares of Class A Common Stock outstanding as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on March 6, 2026, after giving effect to the full exercise of the underwriters' over-allotment option, as described therein.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Platinum Falcon B 2018 RSC Limited ("Platinum Falcon") is the direct owner of 40,838,099 of the shares of Class A Common Stock reported herein. Platinum Falcon is a wholly owned subsidiary of Abu Dhabi Investment Authority. Pursuant to the rules and regulations of the Securities and Exchange Commission, Abu Dhabi Investment Authority may be deemed to be the beneficial owner of the shares of Class A Common Stock directly held by Platinum Falcon. (2) The percent calculation based on 845,611,435 shares of Class A Common Stock outstanding as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on March 6, 2026, after giving effect to the full exercise of the underwriters' over-allotment option, as described therein.


SCHEDULE 13G



Abu Dhabi Investment Authority
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
Date:05/07/2026
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
Date:05/07/2026
Platinum Falcon B 2018 RSC Limited
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
Date:05/07/2026
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
Date:05/07/2026

FAQ

What stake does Abu Dhabi Investment Authority hold in Medline (MDLN)?

Abu Dhabi Investment Authority beneficially owns 41,355,340 shares of Medline Class A Common Stock, representing 4.9% of the class. The percent uses 845,611,435 shares outstanding from Medline's March 6, 2026 prospectus after overallotment.

How many shares does Platinum Falcon hold in Medline (MDLN)?

Platinum Falcon B 2018 RSC Limited beneficially owns 40,838,099 shares of Medline Class A Common Stock, representing 4.8% of the class based on 845,611,435 shares outstanding reported in Medline's March 6, 2026 prospectus.

What basis was used to calculate the ownership percentages in the filing for MDLN?

Percentages are calculated using 845,611,435 shares outstanding as disclosed in Medline's prospectus filed pursuant to Rule 424(b)(4) on March 6, 2026, after giving effect to the full exercise of the underwriters' over-allotment option.